1 Head of the Department of Pediatrics and Neonatology, Urgench State Medical Institute
2 Department of Pediatrics and Neonatology, Urgench State Medical Institute
ReceivedJul 10, 2026
RevisedJul 25, 2026
PublishedJul 30, 2026
Abstract
Background: Prolonged neonatal jaundice requires careful assessment because persistent unconjugated hyperbilirubinemia must be distinguished from conjugated hyperbilirubinemia and hepatobiliary disease. Maternal overweight and obesity may alter maternal and neonatal metabolic conditions, but evidence regarding prolonged jaundice remains limited. Objective: To describe maternal body mass index distribution and clinical–laboratory findings among term newborns with prolonged jaundice. Methods: This clinical and laboratory study included 140 full-term newborns with jaundice persisting beyond 14 days and total bilirubin above 85 μmol/L. Newborns were grouped according to maternal pre-pregnancy BMI. Maternal and neonatal hematological and biochemical indicators were assessed, and Spearman correlations were calculated. Results: Of 140 newborns, 100 (71.4%) were male. Maternal BMI categories were overweight in 57 cases (40.7%), class I–II obesity in 21 (15.0%), underweight in 25 (17.9%), and normal weight in 37 (26.4%). Maternal AST was higher in the overweight and obesity groups than in the normal-BMI group. Mean neonatal biochemical values did not differ significantly across groups. Within the overweight group, platelet count correlated positively with direct bilirubin (ρ=0.63), ALT (ρ=0.95), and AST (ρ=0.79). Conclusion: Overweight or obesity was present in 55.7% of mothers in this case series. The observed laboratory correlations are exploratory and support structured hepatobiliary assessment rather than causal inference..
Keywords
prolonged neonatal jaundice; maternal body mass index; overweight; obesity; hyperbilirubinemia; neonatal cholestasis; liver enzymes.
References
1. Kemper AR, Newman TB, Slaughter JL, Maisels MJ, Watchko JF, Downs SM, et al. Clinical Practice Guideline Revision: Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation. Pediatrics. 2022;150(3):e2022058859. doi:10.1542/peds.2022-058859.
2. National Institute for Health and Care Excellence. Jaundice in newborn babies under 28 days. NICE guideline CG98. Published 19 May 2010; updated 31 October 2023. https://www.nice.org.uk/guidance/cg98
3. Fawaz R, Baumann U, Ekong U, Fischler B, Hadzic N, Mack CL, et al. Guideline for the Evaluation of Cholestatic Jaundice in Infants: Joint Recommendations of NASPGHAN and ESPGHAN. Journal of Pediatric Gastroenterology and Nutrition. 2017;64(1):154–168. doi:10.1097/MPG.0000000000001334.
4. Feldman AG, Sokol RJ. Neonatal Cholestasis: Updates on Diagnostics, Therapeutics, and Prevention. NeoReviews. 2021;22(12):e819–e836. doi:10.1542/neo.22-12-e819.
5. Ranucci G, Della Corte C, Alberti D, Bondioni MP, Boroni G, Calvo PL, et al. Diagnostic approach to neonatal and infantile cholestasis: A position paper by the SIGENP liver disease working group. Digestive and Liver Disease. 2022;54(1):40–53. doi:10.1016/j.dld.2021.09.011.
6. Rougée LRA, Miyagi SJ, Collier AC. Obstetric Obesity is Associated with Neonatal Hyperbilirubinemia with High Prevalence in Native Hawaiians and Pacific Island Women. Hawai‘i Journal of Medicine & Public Health. 2016;75(12):373–378.
7. Özdek S, Kul M, Akcan AB, Çekmez F, Aydemir G, Aydınöz S, et al. The effect of the pre-pregnancy weight of the mother and the gestational weight gain on the bilirubin level of term newborn. Journal of Maternal-Fetal & Neonatal Medicine. 2016;29(15):2434–2437. doi:10.3109/14767058.2015.1086743.
8. Domosud J, Kulik-Rechberger B. Maternal pre-pregnancy BMI and gestational weight gain as risk factors of jaundice in healthy newborns ≥37 weeks of gestation. Journal of Health Inequalities. 2022;8(2):137–144. doi:10.5114/jhi.2022.121530.
9. Lee BK, Le Ray I, Sun JY, Wikman A, Reilly M, Johansson S. Haemolytic and nonhaemolytic neonatal jaundice have different risk factor profiles. Acta Paediatrica. 2016;105(12):1444–1450. doi:10.1111/apa.13470.
10. Lin Q, Zhu D, Chen C, Feng Y, Shen F, Wu Z. Risk factors for neonatal hyperbilirubinemia: a systematic review and meta-analysis. Translational Pediatrics. 2022;11(6):1001–1009. doi:10.21037/tp-22-229.
11. UNICEF. Under-five mortality. UNICEF Data. Updated March 2026. https://data.unicef.org/topic/child-survival/under-five-mortality/
12. UNICEF. Neonatal mortality. UNICEF Data. Updated March 2026. https://data.unicef.org/topic/child-survival/neonatal-mortality/
13. World Health Organization. Obesity and overweight. Fact sheet. 8 December 2025. https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight
14. Yokoda RT, Rodriguez EA. Review: Pathogenesis of cholestatic liver diseases. World Journal of Hepatology. 2020;12(8):423–435. doi:10.4254/wjh.v12.i8.423.
How to Cite
Xudayberganov M, Sharipova S (2026). MATERNAL PRE-PREGNANCY BODY MASS INDEX AMONG TERM NEWBORNS WITH PROLONGED JAUNDICE: CLINICAL AND LABORATORY FINDINGS. Science and Innovation, 5(7), 54-64. https://doi.org/10.67620/sai.57d0007